The changing landscape of atherosclerosis

2021/04/21 by Peter Libby · 29 citations
Immunology and Microbiology · Medicine · #Adipokines, Inflammation, and Metabolic Diseases #Atherosclerosis and Cardiovascular Diseases #Lipid metabolism and disorders

paper · doi:10.1038/s41586-021-03392-8

crossref issued 2021/04/21 · crossref published 2021/04/21 · crossref published-online 2021/04/21 · openalex publication_date 2021/04/21 · crossref created 2021/04/21 · crossref published-print 2021/04/22 · crossref deposited 2023/05/20 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Cited by

• Acute coronary syndromes: mechanisms, challenges, and new opportunities
• Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review
• A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice
• Impact of the gut microbiome on atherosclerosis
• Stigmasterol attenuates atherosclerosis by inhibiting inflammatory signaling and foam cell formation
• Food insecurity is associated with glycemic markers, and socioeconomic status and low-cost diets are associated with lipid metabolism in Mexican mothers
• The Role of Inflammation in Cardiovascular Disease
• Carbohydrate Restriction-Induced Elevations in LDL-Cholesterol and Atherosclerosis
• SEC16B identified as a regulator of VLDL secretion and lipid accumulation in the liver
• Hepatic SEC16B regulates lipid homeostasis by coordinating VLDL secretion and lipid droplet expansion
• The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets
• A systems view of the vascular endothelium in health and disease
• Exploring the anti-atherosclerosis mechanism of ginsenoside Rb1 by integrating network pharmacology and experimental verification
• Lipoprotein(a)-associated proteomic signature predicts cardiovascular disease in young adults
• Serum phthalates and risks of incident cardiovascular disease among individuals with type 2 diabetes in a prospective cohort study
• Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion
• Low-dose interleukin-2 induces clonal expansion of BACH2-repressed effector regulatory T cells following acute coronary syndrome
• RETRACTED: Longitudinal Data From the KETO-CTA Study
• Current landscape and future directions of drug-eluting balloons in cardiovascular interventions
• The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine
• Understanding coronary bypass grafts from mechanical constitutive models to machine learning: A review
• Cholesterol induced-mitochondrial calcium dysregulation facilitates atherosclerosis by promoting lipid accumulation in vascular smooth muscle cells
• Trained Immunity in Health and Disease
• Emerging roles of the cGAS/STING pathway in cardiovascular diseases
• The time-varying prognostic value of stenosis and plaque burden in coronary artery disease
• An azo substituted quinoline‐malononitrile enzyme‐activable aggregation‐induced emission nanoprobe for hypoxia imaging
• Endothelial-to-mesenchymal transition primes vascular endothelial cells toward an osteochondrogenic fate
• Colchicine inhibits macrophage motility and matrix degradation through microtubule disruption
• Pathophysiology of Atherosclerosis